BSE filing, NSE: CHEMIESYNT. Summary written from the filing by ALFA Finder's alert engine.
Chemiesynth (Vapi) Ltd: key numbers
- Share price
- ₹145.80
- Market cap
- ₹44.76 Cr
- Revenue (annual)
- ₹21.44 Cr
- Net profit (annual)
- ₹-0.99 Cr
- P/E (TTM)
- -40.1×Sector 34.5×
- Promoter holding
- 62.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemiesynth (Vapi) Ltd
All →Chemiesynth (Vapi) Debt & Borrowing: ₹10 Cr
Chemiesynth's board approved allotment of 1 crore unlisted NCRPS at ₹10 par, raising ₹10 Crore. The 7-year, 5% unsecured shares are issued via private placement.
- Value
- ₹10.00 Cr
- Execution
- 7 years (28-10-2026 to 28-10-2033)
Chemiesynth (Vapi) Board Meeting Date
Chemiesynth (Vapi) Ltd notified a board meeting scheduled for 28 October 2026. The agenda includes approval of unlisted NCRPS allotment on private placement basis.
Chemiesynth (Vapi) Annual General Meeting
Chemiesynth (Vapi) Ltd held its 40th AGM, approving the adoption of financial statements and the reappointment of Mr. Rushabh Mehta as Director. Shareholders also approved an increase in authorised share capital to ₹18.25 Crore.
Chemiesynth (Vapi) Annual General Meeting
Chemiesynth (Vapi) Limited has issued a notice for its 40th Annual General Meeting scheduled for September 30, 2026. The filing includes the Annual Report web-link.
Chemiesynth (Vapi) Annual Report
Chemiesynth (Vapi) Ltd has scheduled its 40th Annual General Meeting for September 30, 2026. The company also released its Annual Report for the 2025-26 fiscal year.
Chemiesynth (Vapi) Annual General Meeting
Chemiesynth (Vapi) Ltd issued a corrigendum to correct clerical errors in the Share Transfer Book Closure and Benpose dates for its upcoming AGM.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.